Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jack V Greiner, OD, DO, PhD
Ophthalmic Research Associates, North Andover, MA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Bel Air, Maryland, United States
- Facility name not stated
North Andover, Massachusetts, United States
- Facility name not stated
Las Vegas, Nevada, United States
- Facility name not stated
Charlotte, North Carolina, United States
- Facility name not stated
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2005
- Primary completion
- 31 Dec 2005
- Completion
- —
- Last update posted
- 20 Feb 2015
- Registered enrollment
- 900
- Registry id
- NCT00223951
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.